序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
1 Benzylisoquinoline alkaloids (BIA) producing microbes, and methods of making and using the same US14211611 2014-03-14 US09534241B2 2017-01-03 Christina D. Smolke; Catherine Thodey; Isis Trenchard; Stephanie Galanie
Aspects of the invention include host cells that are engineered to produce benzylisoquinoline alkaloids (BIAs). The host cells include heterologous coding sequences for a variety of enzymes involved in synthetic pathways from starting compounds to BIAs of the host cell. Also provided are methods of producing the BIAs of interest by culturing the host cells under culture conditions that promote expression of enzymes encoded by the heterologous coding sequences of the host cells. Aspects of the invention further include compositions, e.g., host cells, starting compounds and kits, etc., that find use in methods of the invention.
2 BENZYLISOQUINOLINE ALKALOIDS (BIA) PRODUCING MICROBES, AND METHODS OF MAKING AND USING THE SAME US14211611 2014-03-14 US20140273109A1 2014-09-18 Christina D. Smolke; Catherine Thodey; Isis Trenchard; Stephanie Galanie
Aspects of the invention include host cells that are engineered to produce benzylisoquinoline alkaloids (BIAs). The host cells include heterologous coding sequences for a variety of enzymes involved in synthetic pathways from starting compounds to BIAs of the host cell. Also provided are methods of producing the BIAs of interest by culturing the host cells under culture conditions that promote expression of enzymes encoded by the heterologous coding sequences of the host cells. Aspects of the invention further include compositions, e.g., host cells, starting compounds and kits, etc., that find use in methods of the invention.
3 Benzylisoquinoline alkaloids (BIA) producing microbes, and methods of making and using the same US15360763 2016-11-23 US10017799B2 2018-07-10 Christina D. Smolke; Catherine Thodey; Isis Trenchard; Stephanie Galanie
Aspects of the invention include host cells that are engineered to produce benzylisoquinoline alkaloids (BIAs). The host cells include heterologous coding sequences for a variety of enzymes involved in synthetic pathways from starting compounds to BIAs of the host cell. Also provided are methods of producing the BIAs of interest by culturing the host cells under culture conditions that promote expression of enzymes encoded by the heterologous coding sequences of the host cells. Aspects of the invention further include compositions, e.g., host cells, starting compounds and kits, etc., that find use in methods of the invention.
4 Polypeptides Having Berberine Bridge Enzyme Like Activity and Polynucleotides Encoding Same US14375402 2013-01-29 US20150152455A1 2015-06-04 Kirk Matthew Schnorr; Junxin Duan; Lars Kiemer; Hong Zhi Huang
Provided are isolated polypeptides having Berberine Bridge Enzyme Like activity, catalytic domains, FAD binding domains and polynucleotides encoding the polypeptides, catalytic domains or FAD binding domains. The nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or FAD binding domains are also provided.
5 BENZYLISOQUINOLINE ALKALOIDS (BIA) PRODUCING MICROBES, AND METHODS OF MAKING AND USING THE SAME US15978005 2018-05-11 US20180334695A1 2018-11-22 Christina D. Smolke; Catherine Thodey; Isis Trenchard; Stephanie Galanie
Aspects of the invention include host cells that are engineered to produce benzylisoquinoline alkaloids (BIAs). The host cells include heterologous coding sequences for a variety of enzymes involved in synthetic pathways from starting compounds to BIAs of the host cell. Also provided are methods of producing the BIAs of interest by culturing the host cells under culture conditions that promote expression of enzymes encoded by the heterologous coding sequences of the host cells. Aspects of the invention further include compositions, e.g., host cells, starting compounds and kits, etc., that find use in methods of the invention.
6 BENZYLISOQUINOLINE ALKALOIDS (BIA) PRODUCING MICROBES, AND METHODS OF MAKING AND USING THE SAME US15360763 2016-11-23 US20170145454A1 2017-05-25 Christina D. Smolke; Catherine Thodey; Isis Trenchard; Stephanie Galanie
Aspects of the invention include host cells that are engineered to produce benzylisoquinoline alkaloids (BIAs). The host cells include heterologous coding sequences for a variety of enzymes involved in synthetic pathways from starting compounds to BIAs of the host cell. Also provided are methods of producing the BIAs of interest by culturing the host cells under culture conditions that promote expression of enzymes encoded by the heterologous coding sequences of the host cells. Aspects of the invention further include compositions, e.g., host cells, starting compounds and kits, etc., that find use in methods of the invention.
7 ベンジルイソキノリンアルカロイド(BIA)産生生物、ならびにそれらを作製および使用する方法 JP2016502637 2014-03-14 JP2016512046A 2016-04-25 クリスティーナ ディー. スモルク; キャサリーン ソーデイ; イシス トレンチャード; ステファニー ギャラニー
本発明の局面は、ベンジルイソキノリンアルカロイド(BIA)を産生するように操作された宿主細胞を含む。宿主細胞は、出発化合物からBIAへの宿主細胞の合成経路に関与する様々な酵素の異種コード配列を含む。また、宿主細胞の異種コード配列によってコードされる酵素の発現を促進する培養条件下で宿主細胞を培養することによって、関心対象のBIAを産生する方法も提供される。本発明の局面は、本発明の方法に使用される構成物、例えば宿主細胞、出発化合物、およびキット等をさらに含む。
8 POLYPEPTIDES HAVING BERBERINE BRIDGE ENZYME LIKE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME EP13743709 2013-01-29 EP2809778A4 2015-08-05 SCHNORR KIRK MATTHEW; DUAN JUNXIN; KIEMER LARS
9 BENZYLISOQUINOLINE ALKALOIDS (BIA) PRODUCING MICROBES, AND METHODS OF MAKING AND USING THE SAME EP14729501.8 2014-03-14 EP2970999A2 2016-01-20 SMOLKE, Christina D.; THODEY, Catherine; TRENCHARD, Isis; GALANIE, Stephanie
Aspects of the invention include host cells that are engineered to produce benzylisoquinoline alkaloids (BIAs). The host cells include heterologous coding sequences for a variety of enzymes involved in synthetic pathways from starting compounds to BIAs of the host cell. Also provided are methods of producing the BIAs of interest by culturing the host cells under culture conditions that promote expression of enzymes encoded by the heterologous coding sequences of the host cells. Aspects of the invention further include compositions, e.g., host cells, starting compounds and kits, etc., that find use in methods of the invention.
10 POLYPEPTIDES HAVING BERBERINE BRIDGE ENZYME LIKE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME EP13743709.1 2013-01-29 EP2809778A1 2014-12-10 SCHNORR, Kirk Matthew; DUAN, Junxin; KIEMER, Lars
Provided are isolated polypeptides having Berberine Bridge Enzyme Like activity, catalytic domains, FAD binding domains and polynucleotides encoding the polypeptides, catalytic domains or FAD binding domains. The nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or FAD binding domains are also provided.
11 BENZYLISOQUINOLINE ALKALOIDS (BIA) PRODUCING MICROBES, AND METHODS OF MAKING AND USING THE SAME PCT/US2014027833 2014-03-14 WO2014143744A2 2014-09-18 SMOLKE CHRISTINA D; THODEY CATHERINE; TRENCHARD ISIS; GALANIE STEPHANIE
Aspects of the invention include host cells that are engineered to produce benzylisoquinoline alkaloids (BIAs). The host cells include heterologous coding sequences for a variety of enzymes involved in synthetic pathways from starting compounds to BIAs of the host cell. Also provided are methods of producing the BIAs of interest by culturing the host cells under culture conditions that promote expression of enzymes encoded by the heterologous coding sequences of the host cells. Aspects of the invention further include compositions, e.g., host cells, starting compounds and kits, etc., that find use in methods of the invention.
QQ群二维码
意见反馈